Related Experiment Videos
Inhibition of differentiation by leukemia inhibitory factor distinguishes two induction pathways in P19 embryonal
1Roswell Park Cancer Institute, Department of Molecular and Cellular Biology, Buffalo, NY 14263.
Abstract:
The ability of leukemia inhibitory factor (LIF) to block differentiation of P19 embryonal carcinoma (EC) cells under a variety of induction conditions was determined. LIF inhibits differentiation under several conditions which lead to endodermal and mesodermal cell lineages including skeletal and cardiac muscle. In contrast, LIF does not block differentiation when cells are induced under conditions which lead to neuro-ectodermal cell types including neurons and astroglial cells. These studies demonstrate that P19 EC cell differentiation can be divided into LIF sensitive and insensitive pathways which correlate with differentiation of endodermal/mesodermal and neuro-ectodermal cell types, respectively. The effect of LIF on mRNA levels for several genes which have previously been implicated in mediating differentiation in P19 EC cells was determined. LIF has no effect on the mRNA levels for retinoic acid receptor (RAR) alpha, RAR beta, RAR gamma, jun A, jun D, c-fos, or fra-1. In contrast LIF stimulates jun B mRNA expression by a factor of four to six under all induction conditions.
Insights
Leukemia inhibitory factor (LIF) blocks P19 embryonal carcinoma (EC) cell differentiation into endodermal and mesodermal lineages but not neuro-ectodermal ones. LIF specifically stimulates jun B mRNA, indicating distinct differentiation pathways.
Area of Science:
- Developmental Biology
- Cell Differentiation
- Molecular Biology
Background:
- P19 embryonal carcinoma (EC) cells are a model system for studying early cell differentiation.
- Leukemia inhibitory factor (LIF) is known to influence stem cell pluripotency and differentiation.
- Understanding differentiation pathways is crucial for regenerative medicine and developmental studies.
Purpose of the Study:
- To investigate the role of leukemia inhibitory factor (LIF) in blocking P19 embryonal carcinoma (EC) cell differentiation.
- To determine if LIF affects differentiation towards specific cell lineages (endodermal, mesodermal, neuro-ectodermal).
- To analyze the impact of LIF on the expression of key genes involved in P19 EC cell differentiation.
Main Methods:
- P19 EC cells were treated with various induction conditions in the presence or absence of LIF.
- Cell differentiation into different lineages was assessed.
- Messenger RNA (mRNA) levels of specific genes (RARs, jun, fos) were quantified using techniques like RT-PCR or Northern blotting.
Main Results:
- LIF effectively inhibited differentiation into endodermal and mesodermal cell types (e.g., muscle).
- LIF did not inhibit differentiation into neuro-ectodermal cell types (e.g., neurons, astroglial cells).
- LIF significantly upregulated jun B mRNA expression (4-6 fold) without affecting other tested genes (RARs, jun A/D, c-fos, fra-1).
Conclusions:
- P19 EC cell differentiation involves distinct LIF-sensitive (endodermal/mesodermal) and LIF-insensitive (neuro-ectodermal) pathways.
- LIF's mechanism involves the specific stimulation of jun B mRNA, suggesting its role in regulating these pathways.
- These findings provide insights into the molecular mechanisms controlling cell fate decisions during early development.